Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.11
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.11). Revenue for the quarter came in at $9.09 million.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
